| Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer Y Ye, Z Zhang, X Fan, X Xu, M Chen, B Chang, Y Zhang Medical oncology 30, 1-7, 2013 | 78 | 2013 |
| Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: an Australian population‐based study Y Ye, P Otahal, TH Marwick, KE Wills, AL Neil, AJ Venn Cancer 125 (3), 442-452, 2019 | 48 | 2019 |
| Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer MM Jin, YZ Ye, ZD Qian, YB Zhang Oncology Letters 10 (5), 3252-3260, 2015 | 38 | 2015 |
| Temporal trends in the risk of developing multiple primary cancers: a systematic review Y Ye, AL Neil, KE Wills, AJ Venn BMC cancer 16, 1-17, 2016 | 32 | 2016 |
| Lung adenocarcinoma cells promote self-migration and self-invasion by activating neutrophils to upregulate Notch3 expression of cancer cells W Peng, Y Sheng, H Xiao, Y Ye, LB Kwantwi, L Cheng, Y Wang, J Xu, ... Frontiers in Molecular Biosciences 8, 762729, 2022 | 17 | 2022 |
| Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine BD Hu, J Guo, YZ Ye, T Du, CS Cheng, Q Jiang, RN Liu, YB Zhang Oncology reports 40 (1), 155-164, 2018 | 16 | 2018 |
| Temporal trends in the risk of second primary cancers among survivors of adult‐onset cancers, 1980 through 2013: an Australian population‐based study Y Ye, P Otahal, KE Wills, AL Neil, AJ Venn Cancer 124 (8), 1808-1818, 2018 | 15 | 2018 |
| Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study L Xu, F Xu, H Kong, M Zhao, Y Ye, Y Zhang BMC cancer 20, 1-10, 2020 | 14 | 2020 |
| Temporal trends in competing mortality from second and subsequent primary cancers, 1980–2014: An Australian population-based study Y Ye, P Otahal, KE Wills, AL Neil, AJ Venn Cancer Epidemiology 55, 61-67, 2018 | 3 | 2018 |
| Overestimation of cardiovascular outcome incidence Y Ye, R Fonseca The Lancet 390 (10112), 2546-2547, 2017 | 1 | 2017 |
| Clinicopathological and molecular characterization of resected lung adenocarcinoma: correlations with histopathological grading systems in Chinese patients W Xia, S Zhang, Y Ye, H Xiao, Y Zhang, G Ning, Y Zhang, W Wang, ... Pathology-Research and Practice, 155359, 2024 | | 2024 |
| Cardiovascular and other competing causes of death among cancer patients, 2006-2015: An Australian population-based study Y Ye, P Otahal, T Marwick, K Wills, A Neil, A Venn Annals of Oncology 29, viii613-viii614, 2018 | | 2018 |
| Temporal trends in the risk of multiple primary cancers and competing mortality among adult-onset cancer patients Y Ye University Of Tasmania, 2018 | | 2018 |
| Risk of second primary cancers and competing mortality in survivors of adult-onset cancer: changing pattern over three decades Y Ye, P Otahal, K Wills, A Neil, A Venn Annals of Oncology 28, v513, 2017 | | 2017 |
| Temporal trends in the risk of developing multiple primary cancers: a systematic Y Ye, AL Neil, KE Wills, AJ Venn | | 2016 |
| Expression of DLL4 in NSCLC and and its clinical significance M Chen, Z Qian, Y YE, Y Zhang Chinese Journal of Clinical and Experimental Pathology, 1368-1370, 1374, 2014 | | 2014 |
| Manuscript title: Cardiovascular and other competing causes of death among cancer patients, 2006-2015: An Australian population-based study Running title: Competing mortality … Y Ye, P Otahal, TH Marwick, KE Wills, AL Neil, AJ Venn, AJ Venn | | |
Alison Vennuniversity of tasmania在 utas.edu.au 的电子邮件经过验证
Alison Vennuniversity of tasmania在 utas.edu.au 的电子邮件经过验证